West Pharmaceutical (WST) PT Raised to $440 at Barclays

October 7, 2026 3:52 AM

Barclays analyst Luke Sergott raised the price target on West Pharmaceutical (NYSE: WST) to $440.00 (from $400.00) while maintaining a Overweight rating.

No results found